Literature DB >> 15887277

Novel mutation in DGUOK in hepatocerebral mitochondrial DNA depletion syndrome associated with cystathioninuria.

Venu T Tadiboyina1, Anthony Rupar, Paul Atkison, Annette Feigenbaum, Jonathan Kronick, Jian Wang, Robert A Hegele.   

Abstract

Mitochondrial depletion syndrome (MDS) refers to a heterogeneous group of mitochondrial disorders characterized by a reduction of the mtDNA copy number in affected tissues. Mutations in DGUOK encoding deoxyguanosine kinase (MIM 601465) cause the hepatocerebral form of MDS (MIM 251880). Cystathioninuria (MIM 219500) can result from mutations in CTH encoding cystathionine gamma lyase (MIM 607657) or can be a secondary finding in several diverse clinical conditions. We present three patients from two apparently unrelated old colony Mennonite families, each of whom had the hepatocerebral form of MDS together with cystathioninuria. Each affected child was homozygous for the novel DGUOK p.D255Y mutation, but had no CTH mutation, indicating that the hepatocerebral form of MDS might be associated with secondary cystathioninuria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887277     DOI: 10.1002/ajmg.a.30748

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  15 in total

1.  Two patients with hepatic mtDNA depletion syndromes and marked elevations of S-adenosylmethionine and methionine.

Authors:  S Harvey Mudd; Conrad Wagner; Zigmund Luka; Sally P Stabler; Robert H Allen; Richard Schroer; Timothy Wood; Jing Wang; Lee-Jun Wong
Journal:  Mol Genet Metab       Date:  2011-11-12       Impact factor: 4.797

2.  Mitochondrial respiratory chain hepatopathies: role of liver transplantation. A case series of five patients.

Authors:  Elisabeth De Greef; John Christodoulou; Ian E Alexander; Albert Shun; Edward V O'Loughlin; David R Thorburn; Vicki Jermyn; Michael O Stormon
Journal:  JIMD Rep       Date:  2011-11-04

Review 3.  Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.

Authors:  Ayman W El-Hattab; Fernando Scaglia
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

4.  Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion.

Authors:  Bénédicte Mousson de Camaret; Jan-Willem Taanman; Sylvie Padet; Maïté Chassagne; Martine Mayençon; Pascale Clerc-Renaud; Ginette Mandon; Marie-Thérèse Zabot; Alain Lachaux; Dominique Bozon
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

5.  Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk.

Authors:  C Lamperti; M Zeviani
Journal:  Acta Myol       Date:  2009-07

Review 6.  Gastrointestinal and hepatic manifestations of mitochondrial disorders.

Authors:  Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2013-05-15       Impact factor: 4.982

7.  Kinetic properties of polymorphic variants and pathogenic mutants in human cystathionine gamma-lyase.

Authors:  Weidong Zhu; Alexander Lin; Ruma Banerjee
Journal:  Biochemistry       Date:  2008-05-14       Impact factor: 3.162

8.  A fatal case of mitochondrial DNA depletion syndrome with novel compound heterozygous variants in the deoxyguanosine kinase gene.

Authors:  Weiyuan Fang; Peng Song; Xinbao Xie; Jianshe Wang; Yi Lu; Gang Li; Kuerbanjiang Abuduxikuer
Journal:  Oncotarget       Date:  2017-09-15

Review 9.  Renal manifestations of genetic mitochondrial disease.

Authors:  John F O'Toole
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-01-31

10.  Reduced mitochondrial DNA content and heterozygous nuclear gene mutations in patients with acute liver failure.

Authors:  Daniel Helbling; Adam Buchaklian; Jing Wang; Lee-Jun Wong; David Dimmock
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-10       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.